Loading data
IMSRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | — | 248.36 k USD | 18.61 k USD |
| Research and development expense | 9.77 m USD | 5.18 m USD | 7.15 m USD |
| Operating profit | -25.2 m USD | -10.35 m USD | -14.24 m USD |
| Profit before tax | -28 m USD | -11.46 m USD | -14.16 m USD |
| Income tax expense | 17.95 k USD | 20.97 k USD | -356.44 k USD |
| Net income (reported basis) | -28.02 m USD | -11.49 m USD | -13.91 m USD |
| Basic earnings per share | -0.39 USD/share | -0.19 USD/share | -20.6 USD/share |
| Diluted earnings per share | -0.39 USD/share | -0.19 USD/share | -20.6 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.